glp-1 tracker app Ro launches supply to help patients navigate shortages Glapp | Semaglutide App &

| Dr Ben Lynch

For type 2 diabetes management , NICE guideline NG28 recommends GLP-1 receptor agonists as a treatment option when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI of 35 kg/m or higher (or lower thresholds for people from South Asian and related minority ethnic backgrounds) Weight loss would benefit other obesity-related comorbidities Continuation of GLP-1 therapy for diabetes typically requires demonstration of beneficial response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months

The use of generic names also has the advantage of avoiding the confusion that can be generated by the different trade names given to drugs according to their mode of administration and/or therapeutic indication (Table 1)

Why is identity testing emphasized so much

Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights

Rhodopsin c tm thy trong vng mc mt ca bn v cc k nhy cm vi nh sng